1.      Bergfeld WF. The pathophysiology of acne vulgaris in children and adolescents, part 1. Cutis. 2004;74(2):92–97.

2.      Çalık MN. Akne Vulgaris’ te Beslenmenin Etkisi. Türkiye Sağlık Bilimleri ve Araştırmaları Dergisi. 2023;6(1):52-62.

3.      Chen Q, Liu C, Tao J, et al. Insights into microbial dysbiosis and Cutibacterium acnes CAMP factor interactions in acne vulgaris. PMC.

4.      Dagnelie MA, et al. The skin microbiome: a new actor in inflammatory acne. PMC.

5.      Dréno B, et al. Microbiome-based therapies in acne: current evidence and future directions. J Eur Acad Dermatol Venereol. 2024.

6.      Gollnick HPM, et al. Acne pathogenesis and new therapeutic targets. Dermatology. 2024.

7.      Haddad J, El Mersani A. Recent advances in understanding inflammatory acne: the Th17 inflammatory pathway. PubMed.

8.      Layton AM, Burns T, Breathnach S, et al. Disorders of the sebaceous glands. In: Rook’s Textbook of Dermatology. Wiley-Blackwell.

9.      Li Y, et al. Precision dermatology in acne: multi-omics and AI-driven models. Exp Dermatol. 2025.

10.  Lu Y, et al. Photodynamic therapy in acne: an updated systematic review. Lasers Med Sci. 2024.

11.  Mancini AJ, Shinkai K, Duran JM, et al. Prepubertal acne: a retrospective study. Int J Womens Dermatol. 2021.

12.  Palmieri SA. Acne vulgaris in children and adolescents: what’s the cause and how to combat it. J Pediatr Pharmacol Ther. 2025;30(3):401–406.

13.  Pariser DM, et al. Topical minocycline foam for acne: efficacy and safety results. J Drugs Dermatol. 2020.

14.  Que SKT, Whitaker-Worth DL, Chang MW. Pathologic acne in pre-pubertal children. PubMed.

15.  Rimon A, et al. Bacteriophage therapy targeting Cutibacterium acnes: preclinical evidence. Nat Commun. 2023.

16.  Schachner LA, Eichenfield L, Andriessen A, et al. Consensus on neonatal through preadolescent acne. J Drugs Dermatol. 2020;19(6):592–600.

17.  Serna-Tamayo C, Janniger CK, Micali G, Schwartz RA. Neonatal and infantile acne vulgaris: an update. MDedge Dermatology.

18.  Sezen B. IGF-1 sistemi ve genetik polimorfizm ile akne vulgaris ilişkisi. Tez.

19.  Thiboutot DM, Zaenglein AL. Advances in the understanding and treatment of acne. J Invest Dermatol. 2024.

20.  Ünal İ. Aknede Tanısal Testler. Turkderm-Turkish Archives of Dermatology & Venereology. 2020 Jan 2;54.

21.  US Food and Drug Administration. Winlevi (clascoterone) 1% cream approval summary. FDA; 2020.

22.  Zouboulis CC, et al. The primary role of sebum in the pathophysiology of acne vulgaris and its therapeutic relevance. PubMed.